NCT Number: NCT01790256
Comparison of Two Temperatures to Treat Insomnia
Insomnia patients demonstrate subjective and physiological hyperarousal. The Cereve Sleep System has been proposed as a clinical treatment to reverse this hyperarousal in insomnia patients. The current study is a two dose study to determine the optimal temperature for the Cereve Sleep System. Primary outcome measures include EEG sleep measured sleep latency and sleep efficiency.
Looking for future studies?
Notify MeKey information
Conditions
Age range
22 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Paul Wylie, Little Rock, Arkansas, United States
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Age >/= 22
Diagnosis of insomnia that meets criteria for DSM IV diagnosis of primary insomnia and International Classification of Sleep Disorders (ICSD)general insomnia criteria and RDC insomnia disorder criteria
Subjects must remain alcohol-free and avoid drugs that could affect sleep during the study.
>14 on the Insomnia Severity Index
Sleep -Wake diaries demonstrate sleep efficiency <85% on at least 50% of nights
Exclusion criteria
Neuropsychiatric disorders that may independently affect sleep, brain function or cognition, such as current major syndromal psychiatric disorders, including DSM-IV mood, anxiety, psychotic, and substance use disorders.
Specific exclusionary diagnoses include major depressive disorder, dysthymic disorder, bipolar disorder, panic disorder, obsessive compulsive disorder, generalized anxiety disorder, any psychotic disorder, and any current substance use disorder.
Unstable medical conditions Raynaud's Disease
Irregular sleep schedules including shift workers;
A latency to persistent sleep < 15 on either the sleep disorder screening night or the baseline PSG sleep night;
A sleep efficiency > 85% on either the sleep disorder screening night or the baseline PSG sleep night;
An AHI (apnea hypopnea index) > 10 and/or a periodic limb movement arousal index (PLMAI) > 15 from SN1
Body Mass Index >34
Use of medications known to affect sleep or wake function
Consumption of more than one alcoholic drink per day, or more than 7 drinks per week prior to study entry.
Caffeinated beverages > 4/day or the equivalent of more than 4 cups of coffee Unable to read or understand English
Treatment and study plan
Cereve Sleep System at 14-16 degrees C
DevicePrimary outcomes
-
Polysomnographically determined sleep latency as changed from baseline measures
Time frame: 1-2 weeks
Polysomnographically determined sleep parameters
-
Poloysomnographically determined sleep efficiency as changed from baseline measures
Time frame: 1-2 weeks
Sponsors and collaborators
Lead sponsor
Cereve, Inc.
Industry
Registry information
Official study title
A Multi-center Prospective, Blinded, Randomized Crossover Study to Compare the Cerêve Sleep System at Two Different Temperatures in Primary Insomnia Patients
Important dates
- Study start
- 2013
- Primary completion
- 2013
- Study completion
- 2013
- First posted
- Feb 13, 2013
- Registry last updated
- May 22, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Better Nights, Better Days for Children With Neurodevelopment Disorders
NCT02694003
Alcohol-Induced Disorders, Alcohol-Related Disorders
Halifax, Nova Scotia, Canada
View Trial DetailsBetter Nights, Better Days for Typically Developing Children
NCT02243501
Dyssomnias, Mental Disorders
Halifax, Nova Scotia, Canada
View Trial DetailsA High Density EEG Comparison of Sleep Patterns in Insomnia
NCT01960452
Dyssomnias, Mental Disorders
Madison, Wisconsin, United States
View Trial DetailsSleep Inducing And Maintaining Efficacy Of Circadin In Elderly Insomniacs
NCT00816673
Dyssomnias, Mental Disorders
Centre Hospitalier de Rouffach, France
View Trial Details